within Pharmacolibrary.Drugs.ATC.M;

model M01AB10
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.8,
    Cl             = 0.0008333333333333334,
    adminDuration  = 600,
    adminMass      = 0.02,
    adminCount     = 1,
    Vd             = 0.015,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0016666666666666668,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Fentiazac is a non-steroidal anti-inflammatory drug (NSAID) of the oxicam class, related to piroxicam and used for the treatment of pain and inflammation in musculoskeletal and joint disorders. Its use has been discontinued and it is not currently approved or marketed for medical use.</p><h4>Pharmacokinetics</h4><p>No published pharmacokinetic studies or specific human PK data for fentiazac are available. The following parameters are rough estimates, extrapolated from structurally related oxicams (e.g. piroxicam, tenoxicam) and general NSAID pharmacokinetics in healthy adults.</p><h4>References</h4><ol><li><p>Dowell, PS, et al., &amp; Whiteland, H (1984). The pharmacokinetics of fentiazac and its metabolite, p-hydroxyfentiazac, after twice-daily oral administration to male volunteers. <i>Xenobiotica; the fate of foreign compounds in biological systems</i> 14(12) 947–953. DOI:<a href=&quot;https://doi.org/10.3109/00498258409151493&quot;>10.3109/00498258409151493</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/6531942/&quot;>https://pubmed.ncbi.nlm.nih.gov/6531942</a></p></li><li><p>Quattrini, M, et al., &amp; Silvestri, S (1981). Serum and urinary levels of fentiazac after a single oral and epicutaneous administration in human subjects. <i>Arzneimittel-Forschung</i> 31(6) 1046–1048. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/7196238/&quot;>https://pubmed.ncbi.nlm.nih.gov/7196238</a></p></li><li><p>Franklin, RA, et al., &amp; Rhenius, ST (1984). Preliminary studies on the fate of 14C-fentiazac in man. <i>Xenobiotica; the fate of foreign compounds in biological systems</i> 14(12) 956–960. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/6531943/&quot;>https://pubmed.ncbi.nlm.nih.gov/6531943</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end M01AB10;
